Stay updated on Grapiprant and Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Grapiprant and Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Grapiprant and Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page's revision version was updated from v3.6.3 to v3.6.4, indicating a new deployment. This update does not modify the study details or functionality presented to users.
    Difference
    0.1%
    Check dated 2026-07-25T12:29:54.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page version was updated from v3.6.2 to v3.6.3. This represents a routine update that does not alter study information or how a user interacts with the page.
    Difference
    0.1%
    Check dated 2026-07-03T22:55:39.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.2, replacing the previous Revision: v3.6.0; this indicates a new build of the page template rather than substantive changes to the study information.
    Difference
    0.1%
    Check dated 2026-06-27T01:49:45.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    A recruitment status line indicating no participant enrollment was added. Additionally, new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Interventional label formatting was refined from 'Intervention / Treatment' to 'Intervention/Treatment', and a site revision stamp 'Revision: v3.6.0' was introduced.
    Difference
    0.6%
    Check dated 2026-06-12T16:11:36.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5. This reflects a metadata version bump for the study page rather than any substantive alteration to the study details.
    Difference
    0.1%
    Check dated 2026-06-05T09:56:49.000Z thumbnail image
  9. Check
    84 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.3 to v3.5.4, representing a platform update. This change reflects an underlying improvement to the site's build rather than the displayed study content.
    Difference
    0.1%
    Check dated 2026-05-14T23:06:57.000Z thumbnail image

Stay in the know with updates to Grapiprant and Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Grapiprant and Pembrolizumab in NSCLC Clinical Trial page.